Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
5 Results Found
AHA Details Legislative Priorities for Congressional Leaders
Hospitals and health systems are experiencing significant financial pressures that challenge their ability to provide 24/7 care for the patients and communities they serve. As Congress begins to focus on its end-of-the-year work, America’s hospitals and health systems respectfully request that you consider the following priorities.
AHA 340B Advocacy Alliance Bulletin - March 20, 2023
Deceptively branded as an effort to save the 340B program, a legislative campaign by the Pharmaceutical Research and Manufacturers of America, National Association of Community Health Centers and other groups to remove many hospitals, eligible drugs and patients from the 340B program “would only save drug company profits by reducing their already modest financial contribution to the health care safety net,” the AHA and other national hospital groups said in a statement today.
AHA 340B Advocacy Alliance Bulletin - July 22, 2022
The Centers for Medicare & Medicaid Services July 15 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system rates by a net 2.7% in calendar year 2023 compared to 2022.
340B Advocacy Alliance Bulletin: Updates on 340B Legislation, Representatives Letter to HHS
Updates on 340B Legislation, Representatives Letter to HHS
Deadline Extended Until Oct. 29 for Your Representatives to Sign ‘Dear Colleague’ Letter Urging HHS to Take Action
Please contact your representatives today and ask them to sign onto a bipartisan “Dear Colleague” letter to Department of Health and Human Services Secretary Alex Azar expressing concern about recent efforts by Kalderos to transition the 340B Drug Pricing Program from one of up-front discounts to post-sale rebates.